SMO Clinplus Co (SZSE:301257) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:301257 SMO Clinplus Co Ltd SZSE:301257
91 GF Score
Price ¥35.17
GF Value ¥38.90
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is SMO Clinplus Co FFO?

FFO (Funds from operations) only applies to REITs.

SZSE:301257
91GF Score
SMO Clinplus Co Ltd SZSE:301257
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SMO Clinplus Co (SZSE:301257) Overvalued in 2026?

Based on GuruFocus' analysis, SMO Clinplus Co stock appears to be undervalued. The current stock price of ¥35.17 is trading 9.6% below its estimated GF Value™ of ¥38.90. GuruFocus considers SMO Clinplus Co to be Modestly Undervalued.

Key valuation signals for SZSE:301257:

  • FFO:
  • GF Value™: ¥38.90 vs. price of ¥35.17 (9.6% below fair value)
  • GF Score™: 91/100 with 5 warning signs

No single metric tells the full story. See the SZSE:301257 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SMO Clinplus Co Business Description

Address 500 Guangdong Road, 23rd Floor, World Trade Building, Huangpu District, Shanghai, CHN, 200001
SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies, and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.
91GF Score

Get the complete analysis for SZSE:301257

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥35.17
Price
¥38.90
GF Value